| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +30% |
| 3Y CAGR | +21% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +43% |
| 3Y CAGR | +28% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,841.80 +27.80 (0.73%) | 17,589.09 | 20.47 | 4.01 | ||
Natco PharmaNATCOPHARM | ₹820.60 -2.30 (0.28%) | 16,093.62 | 19.4 | 1.46 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,085.30 -161.80 (7.20%) | 15,853.00 | 22.64 | 4.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,043.50 -124.50 (2.02%) | 15,017.38 | 84.5 | 17.09 |